elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38023207-3A783946-3442-4DA4-8248-24E36CA005BD
Q38023207-3A783946-3442-4DA4-8248-24E36CA005BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38023207-3A783946-3442-4DA4-8248-24E36CA005BD
Targeted immunotherapy trials for idiopathic inflammatory myopathies.
P2860
Q38023207-3A783946-3442-4DA4-8248-24E36CA005BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38023207-3A783946-3442-4DA4-8248-24E36CA005BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be54b2ae49679b3e71809ca1392f66681ae6b4a8
P2860
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.